about
Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cellsSubcellular fractionation of TGF-beta1-stimulated lung epithelial cells: a novel proteomic approach for identifying signaling intermediates.An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthmamiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosismiR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1Persistent infection by HSV-1 is associated with changes in functional architecture of iPSC-derived neurons and brain activation patterns underlying working memory performanceGene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways.Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.Genomic differences distinguish the myofibroblast phenotype of distal lung fibroblasts from airway fibroblasts.Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.Enolase 1 (ENO1) and protein disulfide-isomerase associated 3 (PDIA3) regulate Wnt/β-catenin-driven trans-differentiation of murine alveolar epithelial cells.High IFN-γ and low SLPI mark severe asthma in mice and humans.eQTL of bronchial epithelial cells and bronchial alveolar lavage deciphers GWAS-identified asthma genesProfibrotic role of miR-154 in pulmonary fibrosis.MicroRNAs in idiopathic pulmonary fibrosis.MicroRNA regulatory networks in idiopathic pulmonary fibrosis.Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscumin.Broad-spectrum non-nucleoside inhibitors of human herpesvirusesLet-7d microRNA affects mesenchymal phenotypic properties of lung fibroblasts.Gene Expression Correlated with Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease.
P50
Q24570123-2B431962-17EE-421C-945E-42A393C98CA0Q33413876-9914168E-CA86-44A0-8D4A-923CA9A5A99FQ34036478-83C51482-5852-44CB-A0F1-CFE7AFE1B9E1Q34044475-DB946F25-3299-4B09-AAD9-A2E81F6DAB0FQ34607960-AC32D597-3AF8-4063-A6F0-C4613891F14FQ34700999-5C4383CC-E5DF-49A6-9A84-84857159F704Q34960273-0AB66B81-B35A-41F4-B8AB-65A78109489FQ35077927-65F74F18-E357-4B01-ABE2-C14FC2A3B542Q35684810-B264C948-8C12-4F25-AF5F-7B898E68C42AQ35692028-A0697277-1AC2-4607-88F8-6EA4E7606E86Q35923444-8FACBFEB-B141-46B7-BB18-C17940960F81Q36040504-63E955D3-4208-4F1F-92A4-B0A5547BB925Q36094846-94FF74D9-416C-4450-A42A-55862286A132Q36539603-C2FF8ED8-1C2B-40A8-8399-C47A10B0B36DQ37855082-1442F2E3-74E5-400D-BF92-C96103CFDCB9Q38306947-32EAEAD4-6A08-4FA2-A256-F4DDA98E8FEFQ38334780-C52CB9CB-DCFC-4EA8-AEEA-87062C5E0FAAQ41158008-005F8457-37DE-439E-8FAF-A20FE680288BQ42414811-2D322DFA-1B15-4750-B022-4F937E1C71D2Q46160784-17DC1EF0-58D5-4F6C-9772-A569D92D9786
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jadranka Milosevic
@ast
Jadranka Milosevic
@en
Jadranka Milosevic
@es
Jadranka Milosevic
@nl
Jadranka Milosevic
@sl
type
label
Jadranka Milosevic
@ast
Jadranka Milosevic
@en
Jadranka Milosevic
@es
Jadranka Milosevic
@nl
Jadranka Milosevic
@sl
prefLabel
Jadranka Milosevic
@ast
Jadranka Milosevic
@en
Jadranka Milosevic
@es
Jadranka Milosevic
@nl
Jadranka Milosevic
@sl
P214
P106
P1153
6603725788
P21
P214
P31
P496
0000-0003-0002-8727
P7859
viaf-62771727